Search

Displaying 61 - 72 items out of 79 results
US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR
ILCN article
US Food and Drug Administration Accepts New Drug Application for Ensartinib
US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR
ILCN article
Regulatory News for April 24, 2024
US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR
ILCN article
European Commission Approves Tislelizumab for Three Indications in Non-Small Cell Lung Cancer
ILCN article
In Brief for November 8, 2023
ILCN article
Regulatory Approval Brings New Targeted Treatment Option for NSCLC to European Union
ILCN article
US Approves Osimertinib with Chemotherapy for EGFR+ NSCLC; Approvals Pending in Other Countries
ILCN article
US FDA Approves Frontline Amivantamab Combination for Patients with EGFR exon 20 Insertion-mutated NSCLC
ILCN article
Regulating Artificial Intelligence
ILCN article
US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR
ILCN article
US Food and Drug Administration Accepts New Drug Application for Ensartinib
ILCN article
Regulatory News for April 24, 2024
ILCN article
ALINA Trial Leads to New Treatment Option for Early-Stage ALK+ NSCLC